Successful clinical trial calls for additional larger trials to examine the use of mesenchymal stems cells to improve survival rates and recovery time
Here we outline clinical trials exploring stem cells, emphasizing those looking at utilizing perinatal stem cells derived from cord blood, the umbilical cord, and other placental tissue.
In the wake of the pandemic, the FDA approves multiple clinical trials exploring stem cells as a treatment option for COVID-19.
A quick guide to how your baby’s cord blood and cord tissue stem cells are processed and stored, so they are ready and available for use anytime.
According to a small clinical trial, patients on ventilators due to COVID-19 are 2.5 times more likely to recover following umbilical cord stem cell treatment.
Will we be able to curb this pandemic effectively? Will the solution be a vaccine, an anti-viral, stem cell therapy, or perhaps a combination of all?